https://www.bioocus.com/news/ash-voice-of-china-professor-xian-zhang-high-efficacy-and-safety-of-nanobody-based-anti-bcma-car-t-therapy-in-treating-patients-with-relapsed-or-refractory-multiple-myeloma/ 0.9 weekly 2024-04-09T10:19:00Z https://www.bioocus.com/news/ash-2023-the-voice-of-lu-daopei-sings-on-the-international-stage/ 0.9 weekly 2024-04-09T10:21:06Z https://www.bioocus.com/news/2023-ash-opening-dr-peihua-lu-presents-car-t-for-relapsed-refractory-aml-research/ 0.9 weekly 2024-04-09T10:23:42Z https://www.bioocus.com/news/are-cellular-therapies-the-future-of-autoimmune-disease/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/tils-therapy-emerges-as-the-next-frontier/ 0.9 weekly 2024-06-05T16:42:00Z https://www.bioocus.com/news/2024-hematology-forum/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/2024-ash-meeting/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/cd7-targeted-car-t/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/ns7car-t/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/promoting-health-and-recovery-daily-care-for-leukemia-patients/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/enhancing-the-effectiveness-of-protac-a-groundbreaking-study/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/breakthrough-in-pediatric-autoimmune-disease-car-t-cell-therapy-cures-lupus-patient/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/annual-clinical-blood-management-and-transfusion-technology-training-held-at-yanda-ludaopei-hospital/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/breakthrough-advances-in-natural-killer-nk-cells-over-50-years/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/breakthrough-study-demonstrates-safety-and-efficacy-of-car-t-therapy-in-treating-b-cell-malignancies/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/novel-promoter-strategy-enhances-safety-and-efficacy-of-car-t-therapy-in-acute-b-cell-leukemia/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/lu-daopei-hospital-s-low-dose-cd19-car-t-therapy-shows-promising-results-in-b-all-patients/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/enhanced-antitumor-efficacy-of-4-1bb-based-cd19-car-t-cells-in-treating-b-all/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/innovative-car-t-cell-therapies-transform-treatment-of-b-cell-malignancies/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/pioneering-car-t-therapy-in-b-cell-acute-lymphoblastic-leukemia-shows-unprecedented-efficacy/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/bioocus-advances-the-frontier-in-treating-pediatric-acute-lymphoblastic-leukemia/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/long-term-efficacy-of-cd19-car-t-cell-therapy-in-treating-relapsed-refractory-acute-lymphoblastic-le/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/promising-outcomes-of-cd7-car-t-therapy-combined-with-second-transplant-in-relapsed-t-all-lbl-patien/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/new-hope-for-chemotherapy-refractory-b-cell-lymphoma-car-t-therapy-shows-promising-results/ 0.9 weekly 2024-11-08T10:24:29Z https://www.bioocus.com/news/high-efficacy-of-cd7-car-t-therapy-for-b-cell-malignancies-a-breakthrough-in-cancer-treatment/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/managing-the-side-effects-of-car-t-cell-therapy-key-insights-from-recent-research/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/bioocus-participates-in-igc-2024-to-explore-new-partnerships-and-business-models-in-immuno-gene-and/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/a-new-lease-on-life-successful-cd7-car-t-therapy-bridges-to-transplant-for-15-year-old-with-relapsed/ 0.9 weekly 2024-11-08T10:24:29Z https://www.bioocus.com/news/revolutionizing-gene-editing-advances-in-crispr-cas-technology-in-biomedical-applications/ 0.9 weekly 2024-11-08T10:24:29Z https://www.bioocus.com/news/overcoming-lymphoma-with-dual-car-t-therapy/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/ash-2024-lu-daopei-team-showcases-13-research-achievements-in-hematology/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/new-gene-therapy-achieves-breakthrough-in-treating-sickle-cell-disease-and-thalassemia/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/dr-lu-peihua-presents-breakthrough-in-car-t-therapy-at-the-29th-apbmt-annual-meeting/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/nk-cell-therapy-combined-with-dc-vaccine-shows-dramatic-improvement-in-late-stage-liver-cancer/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/overcoming-leukemia-a-young-girl-s-journey-of-resilience-and-hope-at-lu-daopei-hospital/ 0.9 weekly 2024-11-08T10:24:29Z https://www.bioocus.com/news/surviving-against-the-odds-a-14-year-journey-of-resilience-in-the-fight-against-stage-iv-melanoma/ 0.9 weekly 2024-11-08T10:24:29Z https://www.bioocus.com/news/from-initial-graft-failure-to-full-recovery-a-patient-s-journey-with-lu-daopei-s-advanced-transplant/ 0.9 weekly 2024-11-08T10:24:29Z https://www.bioocus.com/news/understanding-thalassemia-a-comprehensive-guide-to-alpha-and-beta-forms/ 0.9 weekly 2024-11-07T13:54:04Z https://www.bioocus.com/news/brexu-cel-car-t-therapy-shows-promising-results-in-adult-r-r-b-all-patients/ 0.9 weekly 2024-11-11T16:46:41Z https://www.bioocus.com/news/accelerating-car-t-cell-preparation-to-enhance-patient-outcomes/ 0.9 weekly 2024-11-14T16:09:30Z https://www.bioocus.com/news/patient-story-high-risk-b-all-bone-marrow-transplant-at-9-months-two-years-later-a-healthy-start-for/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/multi-center-study-shows-good-prognosis-for-hematologic-malignancy-patients-undergoing-mmud-allogeneic-stem-cell-transplant-with-atg/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/patient-story-from-aml-m2-diagnosis-to-a-university-freshman-a-five-year-journey-to-recovery/ 0.9 weekly 2024-11-27T12:57:03Z https://www.bioocus.com/news/clinical-significance-of-oligoclonal-protein-bands-after-bcma-car-t-therapy-in-multiple-myeloma-patients/ 0.9 weekly 2024-11-27T13:02:04Z https://www.bioocus.com/news/patient-story-overcoming-acute-myeloid-leukemia-and-rebirth-after-stem-cell-transplant/ 0.9 weekly 2024-12-03T15:22:59Z https://www.bioocus.com/news/new-advances-in-primary-central-nervous-system-lymphoma-pcnsl-treatment-and-diagnosis/ 0.9 weekly 2024-12-04T16:17:19Z https://www.bioocus.com/news/a-teen-reclaims-hope-after-aml-m4a-diagnosis-a-journey-of-resilience-and-recovery/ 0.9 weekly 2024-12-05T16:58:12Z https://www.bioocus.com/news/advancements-in-first-line-treatment-for-adult-b-all-a-comprehensive-review-from-the-lancet-haematology/ 0.9 weekly 2024-12-09T13:47:19Z https://www.bioocus.com/news/overcoming-challenges-in-car-t-therapy-for-t-cell-blood-cancers/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/promising-results-for-cd7-car-t-therapy-in-treating-relapsed-refractory-peripheral-t-cell-lymphoma-at-ash-2024/ 0.9 weekly 2024-12-17T13:51:37Z https://www.bioocus.com/news/improved-survival-rates-with-bu-cy-melphalan-and-bu-cy-thiotepa-regimens-in-haploidentical-stem-cell-transplantation-for-non-down-syndrome-acute-megakaryoblastic-leukemia-amkl/ 0.9 weekly 2024-12-17T14:04:14Z https://www.bioocus.com/news/patient-story-acute-myeloid-leukemia-aml-m2-survivor-9-years-post-transplant-embracing-the-power-of-hope-and-rebirth/ 0.9 weekly 2024-12-23T10:04:17Z https://www.bioocus.com/news/academic-breakthrough-lu-daopei-medical-team-publishes-groundbreaking-clinical-study-in-the-british-journal-of-haematology/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/managing-long-term-complications-of-car-t-therapy-insights-from-nature-cancer/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/advancements-in-t-all-risk-stratification-ngs-based-classification-identifies-high-risk-subgroups/ 0.9 weekly 2025-01-03T00:23:16Z https://www.bioocus.com/news/challenges-in-treating-breakthrough-invasive-fungal-disease-in-hematologic-malignancy-patients-insights-from-ash-2024/ 0.9 weekly 2025-01-03T00:33:23Z https://www.bioocus.com/news/menin-inhibitors-a-groundbreaking-therapy-for-acute-myeloid-leukemia/ 0.9 weekly 2025-01-10T12:20:23Z https://www.bioocus.com/news/breakthrough-study-published-in-blood-nanobody-based-cd7-car-t-therapy-for-acute-myeloid-leukemia/ 0.9 weekly 2025-01-10T12:24:09Z https://www.bioocus.com/news/car-t-therapy-a-promising-future-for-t-cell-malignancies/ 0.9 weekly 2025-01-15T13:04:50Z https://www.bioocus.com/news/new-biomarkers-predict-car-t-therapy-outcomes-in-multiple-myeloma-treatment/ 0.9 weekly 2025-01-15T13:17:05Z https://www.bioocus.com/news/breakthrough-study-confirms-safety-and-efficacy-of-cd19-cd20-car-t-therapy-for-r-r-b-nhl/ 0.9 weekly 2025-01-23T13:51:38Z https://www.bioocus.com/news/breakthrough-insights-into-genetic-subtypes-of-adult-b-all/ 0.9 weekly 2025-01-23T14:16:17Z https://www.bioocus.com/news/car-t-therapy-shows-safety-and-effectiveness-in-cancer-patients-with-autoimmune-or-inflammatory-diseases/ 0.9 weekly 2025-02-14T16:45:42Z https://www.bioocus.com/news/early-intervention-with-car-t-therapy-for-large-b-cell-lymphoma-shows-promising-outcomes/ 0.9 weekly 2025-02-14T16:59:42Z https://www.bioocus.com/news/car-t-therapy-overcomes-poor-prognosis-in-high-grade-b-cell-lymphoma/ 0.9 weekly 2025-04-12T12:06:47Z https://www.bioocus.com/news/the-importance-of-regular-follow-up-and-check-ups-after-hematopoietic-stem-cell-transplantation/ 0.9 weekly 2025-02-21T13:59:39Z https://www.bioocus.com/news/australian-patient-achieves-remarkable-early-response-with-bioocus-medical-group-s-dual-cd19-cd20-car-t-therapy-for-relapsed-dlbcl/ 0.9 weekly 2026-04-21T20:48:22Z https://www.bioocus.com/news/bioocus-medical-group-s-dual-cd19-bcma-car-t-therapy-delivers-promising-results-in-refractory-myasthenia-gravis-a-young-patient-s-journey/ 0.9 weekly 2026-04-24T00:00:00Z https://www.bioocus.com/news/genomic-advances-illuminate-t-all-biology-and-pave-the-way-for-improved-risk-stratification-and-targeted-therapies/ 0.9 weekly 2026-05-06T00:00:00Z